Go Pro
NASDAQ:MRM

Medirom Healthcare Technologies (MRM) Stock Price, News & Analysis

Medirom Healthcare Technologies logo
$0.72 -0.05 (-6.77%)
As of 12:25 PM Eastern
This is a fair market value price provided by Massive. Learn more.

About Medirom Healthcare Technologies Stock (NASDAQ:MRM)

Advanced

Key Stats

Today's Range
$0.73
$0.75
50-Day Range
$0.75
$1.08
52-Week Range
$0.70
$4.45
Volume
2,671 shs
Average Volume
261,432 shs
Market Capitalization
$20.38 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

Medirom Healthcare Technologies Inc. is a Japan-based healthcare and wellness company that provides services designed to support preventive care and everyday health management. The company operates wellness and relaxation salons in Japan, offering services such as body care, stretching, reflexology and related treatments through brands including Re.Ra.Ku.

In addition to its salon business, Medirom develops digital healthcare products and services. Its offerings include the MOTHER Bracelet, a wearable device designed to monitor activity and other health-related data without requiring conventional battery charging, as well as related technology intended for use in wellness and healthcare applications.

Founded in 2000, the company is headquartered in Tokyo and primarily serves customers in Japan through directly operated and franchised locations. Medirom Healthcare Technologies is led by founder and Chief Executive Officer Tatsuya Tanimoto. Its American depositary shares trade on the Nasdaq under the symbol MRM.

AI Generated. May Contain Errors.

Medirom Healthcare Technologies Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
11th Percentile Overall Score

MRM MarketRank™: 

Medirom Healthcare Technologies scored higher than 11% of companies evaluated by MarketBeat, and ranked 446th out of 473 stocks in the consumer discretionary sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Medirom Healthcare Technologies has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Medirom Healthcare Technologies has only been the subject of 1 research reports in the past 90 days.

  • Read more about Medirom Healthcare Technologies' stock forecast and price target.
  • Price to Book Value per Share Ratio

    Medirom Healthcare Technologies has a P/B Ratio of 3.10. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.11% of the float of Medirom Healthcare Technologies has been sold short.
  • Short Interest Ratio / Days to Cover

    Medirom Healthcare Technologies has a short interest ratio ("days to cover") of 0.49, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Medirom Healthcare Technologies has recently decreased by 34.43%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Medirom Healthcare Technologies does not currently pay a dividend.

  • Dividend Growth

    Medirom Healthcare Technologies does not have a long track record of dividend growth.

    • Insider Buying vs. Insider Selling

      In the past three months, Medirom Healthcare Technologies insiders have not sold or bought any company stock.

    • Percentage Held by Insiders

      40.24% of the stock of Medirom Healthcare Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.

    • Percentage Held by Institutions

      Medirom Healthcare Technologies has minimal institutional ownership at this time.

    • Read more about Medirom Healthcare Technologies' insider trading history.
    Receive MRM Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for Medirom Healthcare Technologies and its competitors with MarketBeat's FREE daily newsletter.

    SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

    MRM Stock News Headlines

    ALERT: Drop these 5 stocks before the market opens tomorrow!
    The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.tc pixel
    MEDIROM Group Reports Q1 2026 Results
    See More Headlines

    MRM Stock Analysis - Frequently Asked Questions

    Medirom Healthcare Technologies' stock was trading at $1.94 on January 1st, 2026. Since then, MRM shares have decreased by 63.2% and is now trading at $0.7140.

    Medirom Healthcare Technologies (MRM) raised $12 million in an IPO on Tuesday, December 29th 2020. The company issued 800,000 shares at $15.00 per share. Maxim Group LLC served as the underwriter for the IPO.

    Shares of MRM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

    Based on aggregate information from My MarketBeat watchlists, some other companies that Medirom Healthcare Technologies investors own include NVIDIA (NVDA), Broadcom (AVGO), Adobe (ADBE), Arista Networks (ANET), AppLovin (APP), e.l.f. Beauty (ELF) and Disc Medicine (IRON).

    Company Calendar

    Today
    9/23/2026
    Fiscal Year End
    12/31/2026

    Industry, Sector and Symbol

    Stock Exchange
    NASDAQ
    Industry
    Diversified Consumer Services
    Sub-Industry
    N/A
    Current Symbol
    NASDAQ:MRM
    Previous Symbol
    NYSE:MRM
    CIK
    1819704
    Fax
    N/A
    Employees
    1,051
    Year Founded
    N/A

    Profitability

    EPS (Trailing Twelve Months)
    N/A
    Trailing P/E Ratio
    N/A
    Forward P/E Ratio
    N/A
    P/E Growth
    N/A
    Net Income
    N/A
    Net Margins
    N/A
    Pretax Margin
    N/A
    Return on Equity
    N/A
    Return on Assets
    N/A

    Debt

    Debt-to-Equity Ratio
    N/A
    Current Ratio
    N/A
    Quick Ratio
    N/A

    Sales & Book Value

    Annual Sales
    $54.89 million
    Price / Sales
    0.37
    Cash Flow
    $0.10 per share
    Price / Cash Flow
    7.35
    Book Value
    $0.23 per share
    Price / Book
    3.12

    Miscellaneous

    Outstanding Shares
    28,390,000
    Free Float
    16,964,000
    Market Cap
    $20.38 million
    Optionable
    N/A
    Beta
    1.05
    7 Stocks That Could Lead the Next Market Boom Cover

    Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

    Get This Free Report

    This page (NASDAQ:MRM) was last updated on 9/23/2026 by MarketBeat.com Staff.
    From Our Partners